News and Trends 16 Dec 2022
Providence Therapeutics’ mRNA rabies vaccine hits milestone
Providence Therapeutics Holdings Inc. says its new mRNA vaccine program for rabies post-exposure prophylaxis has achieved a preclinical proof-of-concept milestone. …